Pilot Social Support Counseling Intervention for Kidney Transplant Candidates

September 14, 2026 updated by: Allyson Hart

Feasibility pilot social support counseling intervention for kidney transplant candidates

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Individuals who are eligible for kidney transplant will be randomized into two groups, control and interventional counseling. The control group will be given a simple survey to fill and return while the interventional counseling will go through a second counseling session along with members of their social support networks. The interventional counseling will then complete the survey (same as control group). Survey answers will be recorded within REDCAP.

Study Type

Interventional

Enrollment (Actual)

23

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Minnesota
      • Minneapolis, Minnesota, United States, 55415
        • Hennepin Healthcare Research Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Between ages 18-80
  • Being considered for kidney transplant
  • Part of social support network for an individual being considered for kidney transplant.
  • Physically and Mentally able to participate.

Exclusion Criteria

  • Non-English speaking individuals.
  • Individuals with impaired ability to consent.
  • Candidates for combined organ Transplant.
  • Patients who choose to opt out of research.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Usual Pre-Transplant Counseling Intervention

Subjects in the control arm will undergo usual pre-transplant counseling as per the standard of care.
Experimental: Social Support Network Counseling Intervention

Subjects in the intervention arm will undergo an additional pretransplant counseling session along with members of their social support networks between 2-12 weeks after their initial transplant evaluation and counseling
Behavioral: Social support network counseling intervention

Pilot social support counseling intervention for kidney transplant candidates along with their social support networks

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Percentage of Correct Answers on Knowledge of Kidney Transplant Options Assessment
Time Frame: one month

Question key (true/false, multiple choice)

  1. A patient on dialysis has the same level of kidney functioning as a patient with a transplanted kidney.
  2. In general, patients can live at least 5 years longer with a kidney transplant than if they stayed on dialysis.
  3. In general, most people on dialysis are happier with the quality of their lives than people with transplants.
  4. Patients have better health outcomes if they receive a transplant before starting dialysis.
  5. If a patient waits long enough on the waitlist, a matching kidney from someone who has died will definitely become available.
  6. About what percentage of all transplanted kidneys function for at least one year?
  7. Nationally, how long do patients generally wait on the waitlist for a kidney from someone who has died?
  8. Compared to transplants from donors who have died, how long do transplants from living donors last?
  9. What is the chance that a living donor or recipient would die undergoing surgery?
one month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difference in Decisional Conflict Scores
Time Frame: one month

questionnaire (Ottawa Decisional Conflict scale)
one month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Allyson Hart

Collaborators

University of Minnesota

Investigators

  • Principal Investigator: Allyson Hart, MD, Hennepin Healthcare

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2020

Primary Completion (Actual)

May 31, 2021

Study Completion (Actual)

September 30, 2021

Study Registration Dates

First Submitted

April 23, 2020

First Submitted That Met QC Criteria

April 23, 2020

First Posted (Actual)

April 27, 2020

Study Record Updates

Last Update Posted (Actual)

October 6, 2026

Last Update Submitted That Met QC Criteria

September 14, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • HSR 19-4710

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

There might be an exchange of data with our collaborators with the study at the University of Minnesota-Twin Cities

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe